Five9 Inc (FIVN) stock analysis: A simple moving average approach

While Five9 Inc has underperformed by -2.39%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, FIVN fell by -35.34%, with highs and lows ranging from $49.90 to $21.04, whereas the simple moving average fell by -15.38% in the last 200 days.

On June 06, 2025, KeyBanc Capital Markets started tracking Five9 Inc (NASDAQ: FIVN) recommending Overweight. A report published by Cantor Fitzgerald on January 17, 2025, Initiated its previous ‘Overweight’ rating for FIVN. Wells Fargo also Downgraded FIVN shares as ‘Equal Weight’, setting a target price of $40 on the company’s shares in a report dated November 12, 2024. Robert W. Baird August 09, 2024d the rating to Neutral on August 09, 2024, and set its price target from $90 to $40. BofA Securities August 05, 2024d its ‘Underperform’ rating to ‘Buy’ for FIVN, as published in its report on August 05, 2024. RBC Capital Mkts’s report from March 15, 2024 suggests a price prediction of $80 for FIVN shares, giving the stock a ‘Outperform’ rating. Deutsche Bank also rated the stock as ‘Buy’.

Analysis of Five9 Inc (FIVN)

Further, the quarter-over-quarter increase in sales is 13.24%, showing a positive trend in the upcoming months.

To gain a thorough understanding of Five9 Inc’s future performance, several well-rounded types of analysis and research techniques can be used, with equity being among the most crucial. The goal here is to ensure that your current return on equity of -0.90% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 1.89, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.

It is also very valuable to look at average volume as an indicator of volatility for a stock, and FIVN is recording an average volume of 1.88M. On a monthly basis, the volatility of the stock is set at 2.97%, whereas on a weekly basis, it is put at 1.90%, with a loss of -2.80% over the past seven days. Furthermore, long-term investors anticipate a median target price of $37.19, showing growth from the present price of $27.75, which can serve as yet another indication of whether FIVN is worth investing in or should be passed over.

How Do You Analyze Five9 Inc Shares?

The number of employees owning shares of the company should also be considered in addition to the fundamentals. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 2.15%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 106.93% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.

FIVN shares are owned by institutional investors to the tune of 106.93% at present.

Hot this week

Is Fluence Energy Inc (FLNC) a threat to investors?

While Fluence Energy Inc has underperformed by -4.67%, investors...

Investing in USA Rare Earth Inc (USAR) might be a great opportunity, but the stock is a bit undervalued

While USA Rare Earth Inc has underperformed by -2.64%,...

Can you still get a good price for Oklo Inc (OKLO) Shares at this point?

While Oklo Inc has overperformed by 1.14%, investors are...

A stock that deserves closer examination: Altimmune Inc (ALT)

While Altimmune Inc has underperformed by -5.91%, investors are...

Results from Neumora Therapeutics Inc (NMRA) show potential

While Neumora Therapeutics Inc has overperformed by 21.70%, investors...

Topics

Is Fluence Energy Inc (FLNC) a threat to investors?

While Fluence Energy Inc has underperformed by -4.67%, investors...

Can you still get a good price for Oklo Inc (OKLO) Shares at this point?

While Oklo Inc has overperformed by 1.14%, investors are...

A stock that deserves closer examination: Altimmune Inc (ALT)

While Altimmune Inc has underperformed by -5.91%, investors are...

Results from Neumora Therapeutics Inc (NMRA) show potential

While Neumora Therapeutics Inc has overperformed by 21.70%, investors...

Was anything negative for KULR Technology Group Inc (KULR) stock last session?

While KULR Technology Group Inc has underperformed by -7.17%,...

A stock that deserves closer examination: ECD Automotive Design Inc (ECDA)

While ECD Automotive Design Inc has underperformed by -3.45%,...

Klotho Neurosciences Inc (KLTO)’s stock chart: A technical perspective

While Klotho Neurosciences Inc has underperformed by -10.96%, investors...
spot_img

Related Articles

Popular Categories

spot_imgspot_img
US Post News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.